the authors have tested a new preparation of dihydroergotamine ( microgranules in a capsule ) by comparing the clinical results obtained in 30 patients suffering from morning migraine with the plasma levels of the active substance measured in 8 healthy subjects .
C0012291
dihydroergotamine
C0149931
migraine